OR02 Renin-Angiotensin-Aldosterone - Bench to Bedside

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Cardiovascular Endocrinology-Basic/Translational
Friday, April 1, 2016: 11:45 AM-1:15 PM
Room 156 (BCEC)
Chairs:
Celso E. Gomez-Sanchez, MD, Univ of Mississippi Med Ctr, Madison, MS and Eleanor Davies, PhD, BSc, University of Glasgow, Glasgow, United Kingdom

Nothing to Disclose: CEG, ED Disclosure Not Provided: NC, FM
11:45 AM
Jennifer DuPont, PhD1, Amy McCurley1, Joseph C McCarthy1, Shawn B Bender, PhD2, Wendy Baur1, Michael Hill3 and Iris Z Jaffe1, (1)Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA
(2)Research, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO
(3)Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO
12:00 PM
Danielle L Cullinane, Ph.D1, Amanda Elizabeth Garza, BS, PhD1, Jose R Romero1, Gail K Adler2, Luminita H Pojoga1 and Gordon H Williams, MD1, (1)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
(2)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
12:15 PM
Mohammad Zaki Shukri1, Richard H Karas2, Luminita H Pojoga3, Iris Z Jaffe2, Gail K Adler3, Gordon H Williams, MD3 and Jose R Romero3, (1)Medicine, Brigham and Women's Hospital, Boston, MA
(2)Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA
(3)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
12:30 PM
Hadrien Gaël Boyer, PhD, Institute for Research and Innovation in Biomedicine, Inserm U982, Mont-Saint-Aignan, France, Julien Wils, MD, INSERM U982, Institute for Biomedical Research and Innovation, Mont Saint Aignan, France, Arnaud Arabo, PhD, Rouen University, Mont Saint Aignan, France, France, Céline Duparc, PhD, University of Rouen, Inserm U982, Institute for Biomedical Research and Innovation, Mont Saint Aignan, France, Isabelle Boutelet, PhD, Inserm U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine, Rouen University, Mont-Saint-Aignan, France, Herve Lefebvre, MD, PHD, Dept of Endo & Metab Diseases, INSERM U982, Rouen, France and Estelle Louiset, PhD, INSERM U982, Institute for Biomedical Research and Innovation, University of Rouen, Mont Saint Aignan, France
12:45 PM
Rene Baudrand, MD, Department of Endocrinology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile, Jasmine Torrey, BA, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, Gordon H Williams, MD, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA and Anand Vaidya, MD, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
1:00 PM
Nada El Ghorayeb1, Tania L Mazzuco, MD, Ph.D.1, Isabelle Bourdeau, MD1, Eric Thérasse, MD2 and André Lacroix, MD3, (1)Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal, Montreal, QC, Canada
(2)Radiology department, Centre de Recherche du Centre hospitalier de l’Université de Montréal, Montreal, QC, Canada
(3)Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal, Montreal, QC, Canada

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire